FDA steps up scrutiny of stem cell therapies Ruby Khatun Khatun31 Aug 2017 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) is stepping up efforts to better regulate an emerging field of medicine that holds significant promise for...
Merck cholesterol drug cuts heart risk only 9 percent, future unclear Ruby Khatun Khatun31 Aug 2017 9:30 AM ISTA large study of a new type of cholesterol medicine from Merck & Co Inc found it cut the risk of heart attack and death by a modest 9 percent...
DoP accepts Sun Pharmas review petition on fixing price of Volitra Enzo Tablet Ruby Khatun Khatun29 Aug 2017 9:45 AM ISTThe Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical’s review petition against price fixation of “Volitra Enzo Tablet” containing...
Titan Pharma receives FDA clearance to begin clinical study of Parkinsons disease treatment Ruby Khatun Khatun29 Aug 2017 9:32 AM ISTSOUTH SAN FRANCISCO, Calif: Titan Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New...
Maha FDA cancelled 58 manufacturing licenses, suspended 145 for non-compliance Ruby Khatun Khatun28 Aug 2017 4:33 PM ISTNew Delhi: Maharashtra FDA had carried out 2,540 inspections on 2,493 manufacturing units across the state since April 2016 till date and on the basis...
Cure.Fit raises Rs 159 crore in fresh round of funding Ruby Khatun Khatun28 Aug 2017 3:20 PM ISTNew Delhi: Health and wellness start-up Cure.Fit said it has raised USD 25 million (over Rs 159 crore) in a fresh round of funding to expand its...
Piramal Enterprises aims organic growth in pharma segment Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTMumbai: Piramal Enterprises Ltd (PEL) is looking at growing organically in the pharmaceutical segment to move up the value chain and expanding in...
Novartis hopeful for novel heart drug, despite modest benefit Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection...
Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
Propeller Health and GSK expands digital health collaboration for Asthma and COPD Ruby Khatun Khatun28 Aug 2017 9:15 AM ISTMADISON: Propeller Health, a leading digital solution for respiratory medicine, today announced the expansion of its 2015 collaboration with GSK,...
Otsuka enters deal with Mylan for Deltyba to treat MDR-TB Ruby Khatun Khatun27 Aug 2017 11:00 AM ISTTOKYO, HERTFORDSHIRE, England, and PITTSBURGH: Otsuka Pharmaceutical Co. Ltd. and Mylan NV have entered into a license agreement between their...
Kiran Mazumdar Shaw to lead Infy CEO search, may go back to alumni Ruby Khatun Khatun27 Aug 2017 10:30 AM ISTNew Delhi: Former Infoscions may well have a shot at clinching the top job as Infosys CEO, with the company looking at "alumni" along with internal...
